Cargando…

Scientists on the spot: Relaxing the heart in hypertrophic cardiomyopathy

Detalles Bibliográficos
Autores principales:	Gladka, Monika M, van der Velden, Jolanda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Cardiovascular Research Onlife
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202627/ https://www.ncbi.nlm.nih.gov/pubmed/37102235 http://dx.doi.org/10.1093/cvr/cvad049

Ejemplares similares

Scientists on the Spot: The complex inheritance of cardiac disorders
por: Patel, Jyoti, et al.
Publicado: (2019)

Highlights of American Heart Association Scientific Sessions 2020: a virtual experience
por: Adão, Rui, et al.
Publicado: (2021)

Therapeutic gene editing, making a point
por: Smits, Anke M
Publicado: (2019)

The RECOVERY trial: cardiovascular implications of a large, simple randomized trial in COVID-19
por: Pessoa-Amorim, Guilherme, et al.
Publicado: (2021)

Response to: Are endothelial cell proliferation and mesenchymal transition as distinguishing characteristics of 3-week Sugen5416/hypoxia mice model?
por: Rodor, Julie, et al.
Publicado: (2023)

Heterogenous treatment effects: secrets for a reliable treat-to-target trial?
por: Guzik, Tomasz J
Publicado: (2017)

The curious case of dermal fibroblasts: cell identity loss may be a mechanism underlying cardiovascular aging
por: Badi, Ileana
Publicado: (2019)

Inclisiran for the treatment of hypercholesterolaemia: implications and unanswered questions from the ORION trials
por: Cupido, Arjen J, et al.
Publicado: (2020)

Endothelial barrier integrity in COVID-19-dependent hyperinflammation: does the protective facet of platelet function matter?
por: Smeda, Marta, et al.
Publicado: (2020)

ISCHEMIA: new questions from a landmark trial
por: Morrow, Andrew, et al.
Publicado: (2020)

The epitranscriptome: tools to study, manipulate, and exploit RNA modifications
por: Nossent, Anne Yaël
Publicado: (2019)

Up in the air: links between the environment and cardiovascular disease
por: Münzel, Thomas
Publicado: (2019)

Atrial fibrillation after cardiac surgery: to screen or not to screen?
por: Casadei, Barbara, et al.
Publicado: (2021)

Is hypothermia more neuroprotective than avoiding fever after cardiac arrest?
por: Dietrichs, Erik Sveberg, et al.
Publicado: (2021)

New understanding of circulatory blood flow and arterial blood pressure mechanisms
por: Wolff, Christopher Bancroft, et al.
Publicado: (2022)

Limitations of the glycaemic index and the need for nuance when determining carbohydrate quality
por: Kanter, Mitch, et al.
Publicado: (2021)

The post-pandemic legacy: the breakthrough of digital health and telemedicine
por: Bruining, Nico
Publicado: (2021)

Cardiovascular disease in transgender people: recent research and emerging evidence
por: Connelly, Paul J, et al.
Publicado: (2021)

What to expect from drug targeting factor XI?
por: Nagy, Magdolna, et al.
Publicado: (2022)

Transcriptional bursts and heterogeneity among cardiomyocytes in hypertrophic cardiomyopathy
por: Burkart, Valentin, et al.
Publicado: (2022)

Sex-Related Differences in Protein Expression in Sarcomere Mutation-Positive Hypertrophic Cardiomyopathy
por: Schuldt, Maike, et al.
Publicado: (2021)

MYBPC3 mutations are associated with a reduced super-relaxed state in patients with hypertrophic cardiomyopathy
por: McNamara, James W., et al.
Publicado: (2017)

Machine Learning for Predicting Heart Failure Progression in Hypertrophic Cardiomyopathy
por: Fahmy, Ahmed S., et al.
Publicado: (2021)

Editorial: Straight from the heart: Novel insights and future perspectives for cardiac repair
por: Bollini, Sveva, et al.
Publicado: (2023)

Genotype‐specific pathogenic effects in human dilated cardiomyopathy
por: Bollen, Ilse A. E., et al.
Publicado: (2017)

Tale of two hearts: a TNNT2 hypertrophic cardiomyopathy case report
por: Pham, Justin H., et al.
Publicado: (2023)

COVID-19 in Adults With Hypertrophic Cardiomyopathy
por: Arabadjian, Milla E., et al.
Publicado: (2021)

Model Embraced Electromechanical Coupling Time for Estimation of Heart Failure in Patients With Hypertrophic Cardiomyopathy
por: Hu, Su, et al.
Publicado: (2022)

Precision and genomic medicine for dilated and hypertrophic cardiomyopathy
por: Nomura, Seitaro, et al.
Publicado: (2023)

Hypertrophic Cardiomyopathy: From Phenotype and Pathogenesis to Treatment
por: Cheng, Zeyi, et al.
Publicado: (2021)

Peripartum cardiomyopathy and dilated cardiomyopathy: different at heart
por: Bollen, Ilse A. E., et al.
Publicado: (2015)

The effect of inhibition of the Na(+)/H(+) exchanger on the development of hypertrophy in hypertrophic cardiomyopathy
por: Brouwer, Wessel P, et al.
Publicado: (2011)

Dual apical hypertrophic cardiomyopathy and endomyocardial fibrosis pathology
por: Martini, Chiara, et al.
Publicado: (2023)

Anxiety Predicts Poor Prognosis in Patients With Hypertrophic Cardiomyopathy
por: He, Chao-Jie, et al.
Publicado: (2022)

Cardiovascular Imaging in Pregnancy: Valvulopathy, Hypertrophic Cardiomyopathy, and Aortopathy
por: Ismail, Haneen, et al.
Publicado: (2022)

The Combination of Feature Tracking and Late Gadolinium Enhancement for Identification Between Hypertrophic Cardiomyopathy and Hypertensive Heart Disease
por: Liu, Shengliang, et al.
Publicado: (2022)

In-vivo T1 cardiovascular magnetic resonance study of diffuse myocardial fibrosis in hypertrophic cardiomyopathy
por: Brouwer, Wessel P, et al.
Publicado: (2014)

Increased left ventricular torsion in hypertrophic cardiomyopathy mutation carriers with normal wall thickness
por: Rüssel, Iris K, et al.
Publicado: (2011)

Advanced searching for hypertrophic cardiomyopathy heritability in real practice tomorrow
por: Chumakova, Olga S., et al.
Publicado: (2023)

Further Considerations in Childhood-Onset Hypertrophic Cardiomyopathy Genetic Testing
por: Monasky, Michelle M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pilchim802d3ne9q4rmb740qge